HSHui Shi

Hui Shi

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Hui Shi has a total of 9 co-authors. Here are the top co-authors by number of shared publications:

  • Lin Yan

    Functional Experiment Centre, School of Basic Medicine, Ningxia Medical University, Yinchuan 750004, China

    2 shared publications
  • Xiao-Long Wang

    Department of Basic Pharmacology and Toxicology, School of Pharmacy, Ningxia Medical University, Yinchuan, China

    2 shared publications
  • Xiu-Ying Pei

    Key Laboratory of Fertility Preservation and Maintenance of Ministry of Education, School of Basic Medical Sciences, Ningxia Medical University, Yinchuan 750004, China

    2 shared publications
  • Fei Chen

    Department of Basic Pharmacology and Toxicology, School of Pharmacy, Ningxia Medical University, Yinchuan, China

    1 shared publication
  • Hongfeng Quan

    School of Pharmacy, Ningxia Medical University, Yinchuan 750004, China

    1 shared publication
  • Man Zhang

    Department of Basic Pharmacology and Toxicology, School of Pharmacy, Ningxia Medical University, Yinchuan, China

    1 shared publication

Latest Publications

  • Open Access

    Oxymatrine inhibits neuroinflammation by Regulating M1/M2 polarization in N9 microglia through the TLR4/NF-κB pathway

    by Xiao-Long Wang, Fei Chen, Hui Shi, Man Zhang, Lin Yan, Xiu-Ying Pei, Xiao-Dong Peng


  • Open Access

    Effects of Betaine on LPS-Stimulated Activation of Microglial M1/M2 Phenotypes by Suppressing TLR4/NF-κB Pathways in N9 Cells

    by Hui Shi, Xiao-Long Wang, Hong-Feng Quan, Lin Yan, Xiu-Ying Pei, Rui Wang, Xiao-Dong Peng

    Microglia mediate multiple facets of neuroinflammation. They can be phenotypically divided into a classical phenotype (pro-inflammatory, M1) or an alternative phenotype (anti-inflammatory, M2) with different physiological characteristics and biological functions in the inflammatory process. Betaine has been shown to exert anti-inflammatory effects. In this study, we aimed to verify the anti-inflammatory effects of betaine and elucidate its possible molecular mechanisms of action in vitro. Lipopolysaccharide (LPS)-activated microglial cells were used as an inflammatory model to study the anti-inflammatory efficacy of betaine and explore its mechanism of regulating microglial polarisation by investigating the morphological changes and associated inflammatory changes. Cytokine and inflammatory mediator expression was also measured by ELISA, flow cytometry, immunofluorescence, and western blot analysis. Toll-like receptor (TLR)-myeloid differentiation factor 88 (Myd88)-nuclear factor-kappa B (NF-κB) p65, p-NF-κB p65, IκB, p-IκB, IκB kinase (IKK), and p-IKK expression was determined by western blot analysis. Betaine significantly mitigated the production of pro-inflammatory cytokines and increased the release of anti-inflammatory cytokines. It promoted the conversion of the microglia from M1 to M2 phenotype by decreasing the expression of inducible nitric oxide synthase and CD16/32 and by increasing that of CD206 and arginase-1. Betaine treatment inhibited the TLR4/NF-κB pathways by attenuating the expression of TLR4-Myd88 and blocking the phosphorylation of IκB and IKK. In conclusion, betaine could significantly alleviate LPS-induced inflammation by regulating the polarisation of microglial phenotype; thus, it might be an effective therapeutic agent for neurological disorders.